Hearing impairment (HI) is one of the most disabling conditions of major global health burden that contributes adversely to the social and economic development of a country, if not managed properly. A proper assessment of the nationwide burden and etiology of HI is instrumental in the prevention, treatment, and management of the condition. This article sought to perform an expert review of HI in Ghana to determine the present knowledge of its burden and possible causes of the condition. A literature search was conducted in PubMed using the following keywords: “hearing loss” OR “hearing impairment” OR “deafness” AND “Ghana.” The literature was scanned until July 20, 2017, with specific inclusion of targeted landmark and background articles on HI. From the search, 18 of out 5869 articles were selected and considered for the review. The results of the search indicated that there were no extensive studies to determine the national burden of HI in Ghana. However, the few studies assessed suggested that the disease is either acquired or inherited. The burden of acquired HI was higher in adults than children, women than men, and people working in a noisy environment. Regarding the genetic cause, specific founder mutations in GJB2 gene (R143W, L79P, V178A, R184Q, A197S, I203K, and L214P) was the only identified genetic cause of HI in Ghana, but the other HI genes were not investigated. There has been some modest effort to study HI in Ghana, but comprehensive studies on the genetic and environmental etiologies (using the “multi-OMICS” approaches), classification, and burden of HI on Ghana are needed.
Get full access to this article
View all access options for this article.
References
1.
AmedofuGK. (2002). Hearing-impairment among workers in a surface gold mining company in Ghana. Afr J Health Sci, 9, 91–97.
2.
AmedofuGK, OcanseyG, and AntwiBB. (2006). Characteristics of hearing-impairment among patients in Ghana. Afr J Health Sci, 13, 110–116.
3.
AmedofuK, BrobbyGW, and OcanseyG. (1999). Congenital non-syndromal deafness at Adamarobe, an isolated Ghanaian village: Prevalence, incidence and audiometric characteristics of deafness in the village (part I). J Gh Sci Assoc, 1, 63–69.
4.
AwuahP. (2012). Tinnitus among patients in Ghana. J Biol Agric Healthc, 2, 120–125.
5.
AwuahP, DuahIM, and AmedofuGK. (2012). Prevalence of hearing loss in patients with acute otitis media. J Sci Technol (Ghana), 32, 11–17.
6.
BarnardJM, FisherLM, JohnsonKC, et al. (2015). A prospective, longitudinal study of US children unable to achieve open-set speech recognition five years after cochlear implantation. Otol Neurotol, 36, 985–992.
BoatengCA, and AmedofuGK. (2004). Industrial noise pollution and its effects on the hearing capabilities of workers: A study from saw mills, printing presses and corn mills. Afr J Health Sci, 11, 55–60.
9.
BoschJ, NoubiapJJN, DandaraC, et al. (2014). Sequencing of GJB2 in Cameroonians and black South Africans and comparison to 1000 genomes project data support need to revise strategy for discovery of nonsyndromic deafness genes in Africans. OMICS, 18, 705–710.
10.
BrobbyGW, Muller-MyhsokB, and HorstmanRD. (1998). Connexin 26 R143w mutation associated with recessive nonsyndromic sensorineural deafness in Africa. N Engl J Med, 338, 548–550.
11.
CardonLR, and HarrisT. (2016). Precision medicine, genomics and drug discovery. Hum Mol Genet, 25, R166–R172.
12.
ChanDK, and ChangKW. (2014). GJB2-associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype. Laryngoscope, 124, E34–E53.
13.
DavisAC (1989). The prevalence of hearing impairment and reported hearing disability among adults in Great Britain. Int J Epidemiol, 18, 911–917.
14.
De AndrésF, TeránS, HernándezF, TeránE, and LlerenaA. (2016). To genotype or phenotype for personalized medicine? Cyp450 drug metabolizing enzyme genotype–phenotype concordance and discordance in the ecuadorian population. OMICS, 20, 699–710.
15.
FangYK, ChienKY, HuangKY, et al. (2016). Responding to a zoonotic emergency with multi-omics research: Pentatrichomonas hominis hydrogenosomal protein characterization with use of RNA sequencing and proteomics. OMICS, 20, 662–669.
16.
GasmelseedN, SchmidtM, MagzoubM, et al. (2004). Low frequency of deafness-associated Gjb2 variants in Kenya and Sudan and novel GJB2 variants. Hum Mutat, 23, 206–207.
17.
GaspariniP, RabionetR, BarbujaniG, et al. (2000). High carrier frequency of the 35delg deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet, 8, 19–23.
18.
GorlinRJ, TorielloHV, and CohenMM. (1995). Hereditary Hearing Loss and Its Syndromes. New York: Oxford University Press, 9–21.
19.
GyamfiCK, AmankwaaI, Owusu SekyereF, and BoatengD. (2016). Noise exposure and hearing capabilities of quarry workers in Ghana: A cross-sectional study. J Environ Public Health 2016,7054276.
20.
HamelmannC, AmedofuGK, AlbrechtK, et al. (2001). Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana. Hum Mutat, 18, 84–85.
21.
HenryBA, TurnerCW, and BehrensA (2005). Spectral peak resolution and speech recognition in quiet: Normal hearing, hearing impaired, and cochlear implant listeners. J of Acous Soc America, 118, 1111–1121.
HertzanoR, and ElkonR. (2012). High throughput gene expression analysis of the inner ear. Hear Res, 288, 77–88.
24.
HodgsonA, SmithT, GagneuxS, AkumahI, and AdjuikM. (2001). Survival and sequelae of meningococcal meningitis in Ghana. Int J Epidemiol, 30, 1440–1446.
25.
JavidniaH, CarsonN, AwubwaM, ByaruhangaR, MackD, and VaccaniJP. (2014). Connexin gene mutations among ugandan patients with nonsyndromic sensorineural hearing loss. Laryngoscope, 124, E373–E376.
26.
KabahumaRI, OuyangX, DuLL, et al. (2011). Absence of GJB2 gene mutations, the GJB6 deletion (GJB6-D13s1830) and four common mitochondrial mutations in nonsyndromic genetic hearing loss in a South African population. Int J Pediatr Otorhinolaryngol, 75, 611–617.
27.
KegeleJ, HurthH, LacknerP, et al. (2015). Otoacoustic emission testing in Ghanaian children with sickle-cell disease. Trop Med Int Health, 20, 1209–1212.
28.
KitcherED, OcanseyG, AbaidooB, and AtuleA. (2014). Occupational hearing loss of market mill workers in the city of Accra, Ghana. Noise Health, 16, 183–188.
29.
LasisiAO, BademciG, FosterJ, BlantonS, and TekinM. (2014). Common genes for non-syndromic deafness are uncommon in sub-Saharan Africa: A report from Nigeria. Int J Pediatr Otorhinolaryngol, 78, 1870–1873.
30.
LebekoK, BoschJ, NoubiapJJN, DandaraC, and WonkamA. (2015). Genetics of hearing loss in Africans: Use of next generation sequencing is the best way forward. Pan Afri Med J 20,383.
31.
MatsunagaT. (2009). Value of genetic testing in the otological approach for sensorineural hearing loss. Keio J Med, 58, 216–222.
32.
MorellRJ, KimHJ, HoodLJ, et al. (1998). Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med, 339, 1500–1505.
33.
MurrayE, MccabeP, HeardR, and BallardKJ. (2015). Differential diagnosis of children with suspected childhood apraxia of speech. J Speech Lang Hear Res, 58, 43–60.
34.
NorouziV, AziziH, FattahiZ, et al. (2011). Did the GJB2 35delg mutation originate in Iran?. Am J Med Genet A, 155A, 2453–2458.
35.
NyakoEA. (2013). Prevalence of hearing impairment at the Korle-Bu teaching hospital. A dissertation submitted to the University of Ghana,, Legon, 47–71.
36.
OlusanyaBO, NeumannKJ, and SaundersJE, (2014). The global burden of disabling hearing impairment: A call to action. Bull World Health Organ, 92, 367–373.
SchadeG, KotheC, RugeG, HessM, and MeyerCG. (2003). [Non-invasive screening for GJB2 mutations in buccal smears for the diagnosis of inherited hearing impairment]. Laryngorhinootologie, 82, 397–401.
40.
SchmutzhardJ, LacknerP, HelbokR, et al. (2015). Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions—A prospective multicenter cohort study. BMC Med, 13, 125–131.
ShanJ, Chobot-RoddJ, CastellanosR, et al. (2010). Gjb2 mutation spectrum in 209 hearing impaired individuals of predominantly Caribbean Hispanic and African descent. Int J Pediatr Otorhinolaryngol, 74, 611–618.
43.
ShargorodskyJ, CurhanSG, CurhanGC, and EaveyR (2010). Change in prevalence of hearing loss in US adolescents. J Am Med Assoc, 304, 772–778.
44.
SmithRJ, BaleJF, and WhiteKR. (2005). Sensorineural hearing loss in children. Lancet, 365, 879–890.
45.
StevensG, FlaxmanS, BrunskillE, et al. (2013). Global and regional hearing impairment prevalence: An analysis of 42 studies in 29 countries. Eur J Public Health, 23, 146–152.
46.
VonaB, NandaI, HofrichterMA, Shehata-DielerW, and HaafT. (2015). Non-syndromic hearing loss gene identification: A brief history and glimpse into the future. Mol Cell Probes, 29, 260–270.
47.
VosT, BarberRM, BellB, et al. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet, 386, 743–800.
WidénSE, and ErlandssonSI (2004). Self-reported tinnitus and noise sensitivity among adolescents in Sweden. Noise Health, 7, 29–40.
50.
WilsonBS, TucciDL, MersonMH, and O'donoghueGM. (2017). Global hearing health care: New findings and perspectives. Lancet, S0140-6736, 31073–31075.
51.
WonkamA. (2015). Letter to the editor regarding “GJB2, GJB6 or GJA1 genes should not be investigated in routine in non syndromic deafness in people of sub-Saharan African descent.”. Int J Pediatr Otorhinolaryngol, 79, 632–633.
52.
WonkamA, NoubiapJJN, DjomouF, FieggenK, NjockR, and ToureGB. (2013). Aetiology of childhood hearing loss in Cameroon (sub-Saharan Africa). Eur J Med Genet, 56, 20–25.
53.
ZakpalaRN, ArmahFA, SackeyBM, and PabiO. (2014). Night-time decibel hell: Mapping noise exposure zones and individual annoyance ratings in an urban environment in Ghana. Scientifica 2014,892105.
